172 related articles for article (PubMed ID: 15780534)
1. Polycystic ovary syndrome in post-menopausal women--marker of the metabolic syndrome.
Margolin E; Zhornitzki T; Kopernik G; Kogan S; Schattner A; Knobler H
Maturitas; 2005 Apr; 50(4):331-6. PubMed ID: 15780534
[TBL] [Abstract][Full Text] [Related]
2. [Prevalence of metabolic disorders among family members of patients with polycystic ovary syndrome].
Benítez R; Sir-Petermann T; Palomino A; Angel B; Maliqueo M; Pérez F; Calvillán M
Rev Med Chil; 2001 Jul; 129(7):707-12. PubMed ID: 11552437
[TBL] [Abstract][Full Text] [Related]
3. Cardiovascular risks and metabolic syndrome in Hong Kong Chinese women with polycystic ovary syndrome.
Cheung LP; Ma RC; Lam PM; Lok IH; Haines CJ; So WY; Tong PC; Cockram CS; Chow CC; Goggins WB
Hum Reprod; 2008 Jun; 23(6):1431-8. PubMed ID: 18359783
[TBL] [Abstract][Full Text] [Related]
4. Prevalence of the metabolic syndrome in German women with polycystic ovary syndrome.
Hahn S; Tan S; Sack S; Kimmig R; Quadbeck B; Mann K; Janssen OE
Exp Clin Endocrinol Diabetes; 2007 Feb; 115(2):130-5. PubMed ID: 17318774
[TBL] [Abstract][Full Text] [Related]
5. Evaluation of metabolic syndrome frequency and premature carotid atherosclerosis in young women with polycystic ovary syndrome.
Vural B; Caliskan E; Turkoz E; Kilic T; Demirci A
Hum Reprod; 2005 Sep; 20(9):2409-13. PubMed ID: 15919774
[TBL] [Abstract][Full Text] [Related]
6. Analysis of clinical characteristics in large-scale Chinese women with polycystic ovary syndrome.
Shi Y; Guo M; Yan J; Sun W; Zhang X; Geng L; Xu L; Chen Z
Neuro Endocrinol Lett; 2007 Dec; 28(6):807-10. PubMed ID: 18063948
[TBL] [Abstract][Full Text] [Related]
7. The evaluation of metabolic parameters and insulin sensitivity for a more robust diagnosis of the polycystic ovary syndrome.
Amato MC; Galluzzo A; Finocchiaro S; Criscimanna A; Giordano C
Clin Endocrinol (Oxf); 2008 Jul; 69(1):52-60. PubMed ID: 18034780
[TBL] [Abstract][Full Text] [Related]
8. Metabolic characteristics of women with polycystic ovaries and oligo-amenorrhoea but normal androgen levels: implications for the management of polycystic ovary syndrome.
Barber TM; Wass JA; McCarthy MI; Franks S
Clin Endocrinol (Oxf); 2007 Apr; 66(4):513-7. PubMed ID: 17371468
[TBL] [Abstract][Full Text] [Related]
9. Clinical and biochemical characteristics of polycystic ovary syndrome in Korean women.
Chae SJ; Kim JJ; Choi YM; Hwang KR; Jee BC; Ku SY; Suh CS; Kim SH; Kim JG; Moon SY
Hum Reprod; 2008 Aug; 23(8):1924-31. PubMed ID: 18579512
[TBL] [Abstract][Full Text] [Related]
10. The metabolic syndrome in young Korean women with polycystic ovary syndrome.
Park HR; Choi Y; Lee HJ; Oh JY; Hong YS; Sung YA
Diabetes Res Clin Pract; 2007 Sep; 77 Suppl 1():S243-6. PubMed ID: 17610984
[TBL] [Abstract][Full Text] [Related]
11. Characterizing cardiovascular risk in women with polycystic ovary syndrome: more than the sum of its parts?
Chang AY; Wild RA
Semin Reprod Med; 2009 Jul; 27(4):299-305. PubMed ID: 19530063
[TBL] [Abstract][Full Text] [Related]
12. Metabolic syndrome in polycystic ovary syndrome.
Carmina E
Minerva Ginecol; 2006 Apr; 58(2):109-14. PubMed ID: 16582867
[TBL] [Abstract][Full Text] [Related]
13. Cardiovascular disease risk factors in polycystic ovary syndrome.
Dokras A
Semin Reprod Med; 2008 Jan; 26(1):39-44. PubMed ID: 18181081
[TBL] [Abstract][Full Text] [Related]
14. Cardiometabolic risk in polycystic ovary syndrome: a comparison of different approaches to defining the metabolic syndrome.
Cussons AJ; Watts GF; Burke V; Shaw JE; Zimmet PZ; Stuckey BG
Hum Reprod; 2008 Oct; 23(10):2352-8. PubMed ID: 18635531
[TBL] [Abstract][Full Text] [Related]
15. Prevalence of polycystic ovary syndrome in reproductive-aged women with type 2 diabetes.
Amini M; Horri N; Farmani M; Haghighi S; Sattari G; Pornaghshband Z; Aminorroaya A
Gynecol Endocrinol; 2008 Aug; 24(8):423-7. PubMed ID: 18850378
[TBL] [Abstract][Full Text] [Related]
16. Metabolic features of the reproductive phenotypes of polycystic ovary syndrome.
Moran L; Teede H
Hum Reprod Update; 2009; 15(4):477-88. PubMed ID: 19279045
[TBL] [Abstract][Full Text] [Related]
17. An association between non-alcoholic fatty liver disease and polycystic ovarian syndrome.
Brzozowska MM; Ostapowicz G; Weltman MD
J Gastroenterol Hepatol; 2009 Feb; 24(2):243-7. PubMed ID: 19215335
[TBL] [Abstract][Full Text] [Related]
18. Differences in low-grade chronic inflammation and insulin resistance in women with previous gestational diabetes mellitus and women with polycystic ovary syndrome.
Thomann R; Rossinelli N; Keller U; Tirri BF; De Geyter C; Ruiz J; Kränzlin M; Puder JJ
Gynecol Endocrinol; 2008 Apr; 24(4):199-206. PubMed ID: 18382906
[TBL] [Abstract][Full Text] [Related]
19. Association between the polycystic ovary syndrome and the metabolic syndrome in Puerto Rico.
Rabelo Acevedo M; Vick MR
P R Health Sci J; 2005 Sep; 24(3):203-6. PubMed ID: 16329683
[TBL] [Abstract][Full Text] [Related]
20. Metabolic and cardiovascular consequences of polycystic ovary syndrome.
Orio F; Vuolo L; Palomba S; Lombardi G; Colao A
Minerva Ginecol; 2008 Feb; 60(1):39-51. PubMed ID: 18277351
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
